Share
PDF
Other content recommended for you
- Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer
- Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer
- BRCA1 andBRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age
- Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia
- Unique de novo mutation of BRCA2 in a woman with early onset breast cancer
- Breast cancer susceptibility variants alter risks in familial disease
- Retesting of women who are negative for a BRCA1 and BRCA2 mutation using a 20-gene panel
- Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries
- Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening
- Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women